L’impact de la digitalisation sur le Marketing pharmaceutique : Cas Merinal

Abstract

The digit al izat ion has a signif icant impact on pharmaceut ical market ing in Alger ia. This thesis examines this impact and confirms that digit al izat ion offer s ma jor advant ages for pharmaceut ica l companies, such as per sonal ized communicat ion, improved brand vis ibi l it y, and pat ient dat a col lect ion. Companies that invest more in digit al market ing are more successful, reduce cost s , and reach consumer s more ef fect ive ly. However , exist ing laws and regulat ions impose specif ic const raint s, par t icular ly in terms of promot ion and communicat ion. To maximize the benef it s of digit al izat ion, it is essent ia l for companies to enhance their dig it a l market ing ski l ls, improve their onl ine presence, explore new dist r ibut ion channe ls, and est abl ish st rat egic par tner ships. These recommendat ions, tai lored to the Alger ian pharmaceut ica l market , wi l l enable companies to ful ly leverage digit al izat ion whi le consider ing the rapid changes in the digit al landscape and health regulat ions. In conclusion, this research highl ight s the impor tance of digit al izat ion in pharmaceut ica l market ing in Alger ia and provides concrete recommendat ions to maximiz e it s benef it s whi le ensur ing consumer safety and health. I t is crucia l for pharmaceut ica l companies to seize the oppor tunit ies offered by digit al izat ion, adopt innovat ive approaches, and st ay at the forefront of new technologica l t rends. This requires a wi l l ingness to adapt , col laborate with st akeholder s, and have a long- t erm vis ion to create a compet it ive advant age in an ever -evolving landscape. Digit al izat ion opens excit ing new prospect s for pharmaceut ica l market ing in Alger ia and represent s a promis ing path to enhanc e iii communicat ion, bui ld consumer t rust , and st imulat e business growth in the pharmaceut ical indust ry.